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To study the effects of RD on renal artery wall function non-invasively using magnetic
resonance.
Methods and Results
32 patients undergoing RD were included. A 3.0 Tesla magnetic resonance of the renal
arteries was performed before RD and after 6-month. We quantified the vessel sharpness
of both renal arteries using a quantitative analysis tool (Soap-Bubble1). In 17 patients we
assessed the maximal and minimal cross-sectional area of both arteries, peak velocity,
mean flow, and renal artery distensibility. In a subset of patients wall shear stress was
assessed with computational flow dynamics. Neither renal artery sharpness nor renal artery
distensibility differed significantly. A significant increase in minimal and maximal areas (by
25.3%, p = 0.008, and 24.6%, p = 0.007, respectively), peak velocity (by 16.9%, p = 0.021),
and mean flow (by 22.4%, p = 0.007) was observed after RD. Wall shear stress significantly
decreased (by 25%, p = 0.029). These effects were observed in blood pressure responders
and non-responders.
Conclusions
RD is not associated with adverse effects at renal artery level, and leads to an increase in
cross-sectional areas, velocity and flow and a decrease in wall shear stress.
Introduction
It is estimated that 1 out of 50 patients with newly diagnosed hypertension (HT) will develop
resistant HT, which carries an increased risk for cardiovascular and renal complications [1]. In
the past years, several trials have demonstrated the usefulness of renal denervation (RD) as a
PLOSONE | DOI:10.1371/journal.pone.0150662 March 22, 2016 1 / 14
OPEN ACCESS
Citation: Doltra A, Hartmann A, Stawowy P,
Goubergrits L, Kuehne T, Wellnhofer E, et al. (2016)
Effects of Renal Denervation on Renal Artery
Function in Humans: Preliminary Study. PLoS ONE
11(3): e0150662. doi:10.1371/journal.pone.0150662
Editor: Jaap A. Joles, University Medical Center
Utrecht, NETHERLANDS
Received: August 19, 2015
Accepted: February 16, 2016
Published: March 22, 2016
Copyright: © 2016 Doltra et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: AD was supported by a Research Grant
from the European Society of Cardiology (2013).
Philips Healthcare provided support in the form of
salaries for authors (BS), but did not have any
additional role in the study design, data collection and
analysis, decision to publish, or preparation of the
manuscript. The specific roles of this author are
articulated in the ‘author contributions’ section.
Competing Interests: Philips Healthcare provided
support in the form of salaries for BS. This does not
non-pharmacological treatment for resistant hypertension [2–4]. In addition to its blood pres-
sure lowering effect, data from the main RD trials have demonstrated a good safety profile,
without significant renovascular complications or renal function impairment at follow-up [2–
5]. Despite this safety evidence, however, acute optical coherence tomography data has shown
the presence of significant local injury that may be not apparent in angiography [6,7]. The clin-
ical impact of those findings, though, is unknown.
On the other hand, invasive data arising from animal studies suggest that RD could lead to
an increase in peak velocity and renal artery flow [8], but to date no human studies have inves-
tigated this topic. Magnetic resonance (MR) imaging permits the non-invasive anatomic study
of renal arteries and the assessment of hemodynamic parameters related to vessel function [9].
The aim of our study was to assess the effect of RD on renal arteries non-invasively, using
state-of-the-art cardiovascular MR techniques.
Methods
Thirty-two patients with resistant hypertension undergoing RD between April 2012 and
November 2013 were prospectively enrolled. Resistant hypertension was defined as an office
systolic blood pressure (SBP) above the target (140 mm Hg) or mean ambulatory 24-h SBP
>135 mm Hg despite the use of3 antihypertensive agents of different classes, including a
diuretic at maximum or highest tolerated doses [1]. Blood pressure measurement methods are
described in detail elsewhere [10]. A stable antihypertensive medication regime (> 3 month
treatment with stable dosage) was necessary before inclusion. One patient with multiple aller-
gies to antihypertensive preparations was also included. Exclusion criteria were contraindica-
tions to RD (significant renal artery stenosis, renal arteries with a diameter< 4 mm or a
length< 20 mm or presence of multiple renal arteries [11], pseudo-resistant hypertension
(mean ambulatory 24-h SBP<130 mm Hg), secondary hypertension, and GFR< 45 ml/min/
1.73 m2. Patients with general contraindications for the performance of cardiovascular MR
were also excluded.
All patients included underwent a MR study at baseline (1 week before RD) that was
repeated at 6 month follow-up. Blood pressure was determined during both MR exams in
order to quantify renal artery distensibility. Clinical assessment, including serum creatinine
analysis, review of medication compliance and blood pressure determination according to the
Standard Joint National Committee VII Guidelines [12]was also performed at both time
points. A Symplicity Flex system catheter (Medtronic, Minneapolis, MN, USA) was used in the
RD procedure as previously reported [13], with a mean number of ablation points of 5.7 ± 1.2
(right renal artery) and 5.9 ± 1.0 (left renal artery). A positive response to RD was defined as a
reduction of10 mmHg in systolic blood pressure at 6-month follow-up [3]. The study was
approved by the local institutional review board (Charité - Universitätsmedizin Berlin) and
written informed consent was obtained from all patients before inclusion.
MR protocol
All MR studies were performed in a 3.0 Tesla MR scanner (Ingenia, Philips Healthcare, Best,
The Netherlands). The standard anterior and posterior coils were used for signal detection.
Images were acquired during breath-holds of 10–15 s using vector electrocardiogram gating. In
all patients a standard breath-hold 3D contrast-enhanced MR angiography with a spoiled gra-
dient-echo sequence of both renal arteries was performed after administration of 0.1 mg/kg
gadobenate meglumine (Dotarem, Guerbet, Villepinte, France). Typical parameters were TR
4.3 ms, TE 1.4 ms, flip angle 30°, reconstructed voxel size 0.64 x 0.64 x 1.7 mm and number of
slices = 92. (Fig 1A and 1D)
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In a subset of 17 patients flowmeasurements of both renal arteries were obtained using through-
plane breath-hold phase-contrast MR imaging. The imaging plane was obtained perpendicular to
the renal artery, at 10–20 mm from its origin (13.9 ± 2.4 mm for the right renal artery and 12.8 ±
2.7 mm for the left). A gradient-echo sequence with spiral read out (number of interleaves 11, acqui-
sition window 35ms) with retrospective gating and through plane flow encoding was used. Other
parameters were flip angle 20° and voxel size: 0.69 x 0.69 x 8 mm (reconstructed). The encoding
velocity value was individually adjusted according to blood flow velocity. (Fig 1B and 1C)
Post-processing
Renal artery sharpness, a quantitative measure of vessel delineation with higher sharpness val-
ues corresponding to better delineation, was quantified fromMR angiography using the Soap–
Fig 1. Example of renal artery flow and sharpness evaluation. 3D contrast enhanced angiography (A) images of the abdominal aorta and left (white
arrow) and right (dotted arrow) renal artery were postprocessed with the SoapBubble tool, obtaining a 2D representation of the renal artery (B, white arrow
indicating the left renal artery)), which was used to quantify renal artery sharpness. Further, in order to evaluate flow parameters, a perpendicular plane to the
renal artery was obtained (C demonstrating planning on the left renal artery), allowing the assessment of renal artery area (D) and flow (E), both indicated by
red rings (white arrow).
doi:10.1371/journal.pone.0150662.g001
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Bubble software (SoapBubble Tool V3, Philips Medical Systems, Best, The Netherlands) [14].
Several points were manually selected along the renal artery as visualized in MR angiography,
and an automatic 2D representation of the renal artery was obtained (Fig 1E).
From renal artery flow imaging peak velocity, the mean flow, maximal and minimal area,
and renal artery distensibility were calculated. Extended MRWorkSpace 2.6.3.5 (Philips Medi-
cal Systems, Best, The Netherlands) was used for post-processing. The contour of the renal
artery was traced manually on phase-contrast images and was automatically propagated
through all phases. A manual correction was performed if necessary. Peak velocity, mean flow,
and maximal and minimal area were automatically quantified. Renal artery distensibility was
calculated as:
Distensibility ¼ AreaMax  AreaMin
PP  AreaMin
where AreaMax and AreaMin refer to maximal and minimal cross-sectional areas, and PP
refers to pulse pressure [15].
Computational fluid dynamics
Three-dimensional MR angiography data were used for the anatomy assessment and phase-
contrast MR data were used to set peak systolic flow conditions just at the ostium of both renal
arteries. The flow in the reconstructed part of the descending aorta, like flow rates in all other
branches (including renal arteries), was calculated assuming Murray law for a relation between
flow rate and vessel diameter Q~d3 for branching vessels. The anatomy of the aorta was seg-
mented and reconstructed with the software ZIB-Amira (Zuse Institute Berlin, Germany) as
described previously [16]. Flow was simulated using ANSYS1 Fluent1 14.5 (ANSYS Inc.,
Canonsburg, PA, USA). A non-Newtonian blood model was applied using an adapted power
law model as described earlier [17]. A k-ω SST transition turbulence model assuming turbu-
lence intensity of 5% was used. At the inlet of the aorta the plug velocity profile was taken. At
all outlets the outlet boundary condition applying zero diffusion flux for all flow variables and
an overall mass balance correction was applied. High quality unstructured volume meshes
accounting for1 million cells varying with the volume of the aorta were fabricated with the
Gambit1 (ANSYS Inc.) following requirements and a mesh independence study. Convergence
criteria were set to residual errors<10−5.
Statistical analysis
Statistical analysis was performed using SPSS for Windows (version 19, SPSS Inc., Chicago, Illi-
nois). All continuous parameters are given as mean ± standard deviation (median). Categorical
data are summarized as frequencies and percentages. The significance of mean differences
between baseline and 6 month follow-up values were tested with the Student T test for paired
data (if distribution was normal) or the Wilcoxon test (if normality could not be assumed).
The Mann-Whitney test was used to compare changes in outcomes between responders and
non-responders. Pearson’s chi-squared test was used to compare categorical data. Linear
model analysis was performed to assess the interaction of blood pressure with changes in veloc-
ity, maximal area, minimal area, and flow. The Kolmogorov-Smirnov test was used to assess
normality. Intra-class correlation coefficient (ICC) was calculated to evaluate intra- and inter-
observer variability; an ICC> 0.6 was considered “good” and> 0.7 “excellent” [18]. ICC is
given as “ICC (95% confidence interval)”. A p-value< 0.05 was considered statistically
significant.
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Results
In total, 32 resistant hypertension patients undergoing RD were included. All patients under-
went MR renal artery angiography, corresponding to a total of 64 single renal artery angio-
grams. No angiographies were excluded. A subset of 17 patients underwent additional flow
imaging of both renal arteries. Of the 34 single renal arteries examined, two had to be excluded
due to the presence of artifacts. Thus, the final number of flow measurements analyzed was 32.
Finally, 20 renal arteries were assessed with computational flow analysis.
Table 1 summarizes the baseline characteristics of our population. Six months after RD, a sig-
nificant decrease in both systolic and diastolic blood pressure was observed: 155 ± 18 (152) mm
Hg at baseline vs. 145 ± 15 (141) mmHg at follow-up, p = 0.001, and 84 ± 10 (84) mmHg at base-
line vs. 80 ± 10 (80) mmHg, p = 0.014, respectively. Heart rate was also significantly decreased at
follow-up: 70 ± 11 (69) at baseline vs. 66 ± 7 (66), p = 0.022. Renal function was stable 6 months
after RD, without significant differences in creatinine value (0.93 ± 0.2 (0.87) mg/dl at baseline
vs. 0.96 ± 0.2, (0.91) mg/dl at 6 months p = 0.107) or GFR (81.8 ± 18.8 (81.9) ml/min/1.73 m2
before RDN vs. 78.2 ± 17.1 (80.8) ml/min/1.73 m2 at 6 months, p = 0.059) in comparison to base-
line levels. In the 11 patients in whom the Cystatin-C value was available, no differences were
found between the values at baseline and follow-up (0.99 ± 0.16 (0.99) mg/dl vs. 0.99 ± 0.15 (1.1)
mg/dl at 6 months, p = 0.755). A significant decrease in the number of antihypertensive agents
being taken was observed after RD (4.8 ± 1.5 (4) vs. 4.5 ± 1.5 (4), p = 0.044).
Renal artery assessment
Excellent intra- and inter-observer variability was found in all our measurements (S1 Table).
Renal artery sharpness had not significantly changed at follow-up as compared to baseline
Table 1. Baseline characteristics.
Baseline characteristics Patients (n = 32)
Female gender 9 (28%)
Age (yr) 65 ± 7.5 (67)
BMI (kg/m2) 30 ± 4 (30)
Systolic BP (mmHg) 155 ± 18 (152)
Diastolic BP (mmHg) 84 ± 10 (84)
Pulse Pressure (mmHg) 70 ± 11 (69)
Coronary artery disease 16 (50%)
Atrial ﬁbrillation 6 (19%)
Stroke/TIA 3 (9%)




Anti-HT agent medication (n) 4.75 ± 1.5 (4)
ACEI / AT1-blockers 30 (94%)
Renin-inhibitors 3 (9%)
β-blockers 25 (78%)
Calcium Channel blockers 24 (75%)
Diuretics 31 (97%)
Sympatholytics 14 (44%)
BMI: body mass index, BP: blood pressure, Anti-HT: antihypertensive, ACEI: angiotensin converting
enzyme inhibitors.
doi:10.1371/journal.pone.0150662.t001
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(48 ± 6.85 (48) % at baseline vs. 47 ± 7.48 (47) % at follow-up, p = 0.399) (Fig 1). Conversely, a
significant increase in peak velocity (656.72 ± 178.86 (620) mm/s baseline vs. 767.53 ± 301.55
(704) mm/s at follow-up, p = 0.021), maximal cross-sectional area (34.81 ± 9.51 (32.5) mm2
baseline vs. 43.38 ± 16.01 (41) mm2 at follow-up, p = 0.007), minimal cross-sectional area
(24.81 ± 8.03 (23) mm2 baseline vs. 31.09 ± 10.99 (29) mm2 at follow-up, p = 0.008), and mean
flow (5.8 ± 2.84 (5.6) ml/s baseline vs. 7.1 ± 3.48 (6.3) ml/s at follow-up, p = 0.007) was
observed at 6 month follow-up (Figs 2 and 3). No significant changes in renal artery distensibil-
ity were found (6.54 ± 2.49 (5.75) 1/mmHg baseline vs. 6.62 ± 2.62 (6.32) 1/mmHg at follow-
up, p = 0.837) (Table 2) (Figs 2, 3 and 4). There was no significant interaction between blood
pressure and peak velocity, minimal area, maximal area, or renal artery flow in the linear
model analysis. The computerized flow analysis demonstrated a significant decrease in wall
shear stress at 6 month follow-up in comparison to baseline (1.87 ± 1.23 Pa baseline vs. 1.39 ±
0.78 Pa at follow-up, p = 0.029) (Figs 5 and 6).
Fig 2. Change in minimal andmaximal areas after renal denervation. As shown in this box-plot graph, a significant increase in both minimal and maximal
cross-sectional areas 6 months after renal denervation (RDN) was observed.
doi:10.1371/journal.pone.0150662.g002
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Responders vs. non-responders
Of the 32 patients included, 15 (47%) were responders to RD; 17 (53%) were non-responders.
No difference in number of ablation points was observed between both subgroups: right renal
Fig 3. Mean flow change after renal denervation.Renal artery mean flow had increased significantly at follow-up, as shown here.
doi:10.1371/journal.pone.0150662.g003
Table 2. Flowmeasurements by MR.
Renal Arteries (n = 32)
Pre-RDN 6 months p
Peak velocity (mm/s) 656.7 ± 178.9 (620.0) 767.5 ± 301.6 (704.0) 0.021
Mean ﬂow (ml/s) 5.8 ± 2.8 (5.6) 7.1 ± 3.5 (6.3) 0.007
Min. area (mm2) 24.8 ± 8.0 (23.0) 31.1 ± 11 (29.0) 0.008
Max. area (mm2) 34.8 ± 9.5 (32.5) 43.4 ± 16.0 (41.0) 0.007
Distensibility (1/mmHg) 6.5 ± 2.5 (5.8) 6.6 ± 2.6 (6.3) 0.837
Results expressed as mean ± standard deviation (median). Min.: minimal, Max.: maximal. Results correspond to 17 patients and 32 renal arteries in total.
doi:10.1371/journal.pone.0150662.t002
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artery 5.5 ± 1.2 (6) points for non-responders vs. 5.8 ± 1.2 (6) points for responders, p = 0.433,
and left renal artery 5.9 ± 1.0 (6) points for non-responders vs. 5.9 ± 1.0 (6) points for respond-
ers, p = 0.911. Renal artery sharpness did not significantly change after RD, either in respond-
ers (48.87 ± 7.62 (48.47) % baseline vs. 46.91 ± 8.21 (47.14) % at follow-up, p = 0.286) or in
non-responders (47.77 ± 6.16 (47.01) % baseline vs. 47.27 ± 6.90 (48.42) %, at follow-up,
p = 0.632).
Flow measurements were available in 8 responders (14 renal arteries) and 9 non-responders
(18 renal arteries). In non-responders, a significant increase in peak velocity, mean flow, and
maximal and minimal cross-sectional areas was observed, whereas those same parameters
showed a non-significant trend towards an increase in responders. Renal artery distensibility
did not significantly change in any of the subgroups (Table 3).
Fig 4. Change in renal artery distensibility after renal denervation. After minimal and maximal cross-sectional areas were obtained, renal artery
distensibility was calculated. The distensibility values did not significantly differ after renal denervation as compared to baseline.
doi:10.1371/journal.pone.0150662.g004
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When the percentage of change in renal artery sharpness, peak velocity, maximal area, mini-
mal area, and renal artery flow was compared between responders and non-responders no dif-
ferences were observed. A trend was shown towards a greater change in the non-responder
subgroup (S2 Table).
Table 3. Responders vs. non-responders.
Responders (n = 14 renal arteries) Non-responders (n = 18 renal arteries)
Pre- RD 6 months p Pre-RD 6 months p
Peak velocity (mm/s) 732.2 ± 204.4 (694.5) 816.0 ± 387.9 (841.5) 0.272 598.0 ± 134.3 (604.5) 729.8 ± 217.5 (656.0) 0.031
Mean ﬂow (ml/s) 6.6 ± 3.4 (6.0) 7.2 ± 3.8 (5.7) 0.706 5.1 ± 2.2 (5.6) 7.1 ± 3.3 (6.6) 0.002
Min. area (mm2) 26.6 ± 9.6 (23.0) 30.9 ± 10.1 (28.5) 0.197 23.4 ± 6.5 (21.0) 31.2 ± 11.9 (30.5) 0.022
Max. area (mm2) 37.1 ± 10.8 (35.5) 41.6 ± 11.8 (40.0) 0.146 33.0 ± 8.2 (31.5) 44.7 ± 18.9 (43.5) 0.022
Distensibility (1/mmHg) 6.2 ± 2.1 (5.7) 6.2 ± 2.1 (6.0) 0.975 6.8 ±2.8 (6.1) 6.9 ± 3.0 (6.3) 0.811
Results expressed as mean ± standard deviation (median). Min.: minimal, Max.: maximal. Results correspond to 8 responder patients (14 renal arteries)
and 9 non-responder patients (18 renal arteries).
doi:10.1371/journal.pone.0150662.t003
Fig 5. Example of wall shear stress analysis before and 6months after renal denervation. In this example, the extent of red colored areas, representing
higher values of wall shear stress, decreases after renal denervation. Wall shear stress decreased by 25% in the general population.
doi:10.1371/journal.pone.0150662.g005
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Finally, when dividing the population according to heart rate response after RD (decrease in
heart rate vs. increase or no change in heart rate), peak velocity, mean flow, and maximal and
minimal cross-sectional areas showed either a significant increase or a trend towards increase
in both subgroups. Renal artery distensibility did not significantly change (S3 Table).
Discussion
Our results suggest that RD does not have adverse effects at renal artery level. Both renal artery
sharpness and distensibility remained stable after 6 months. Furthermore, our study shows
that disruption of sympathetic stimuli with RD leads to an increase in renal artery cross sec-
tional areas, which in turn leads to a secondary increment in renal artery peak velocity and
flow and a reduction in wall shear stress. The observed effects were found in responders and
non-responders to RD.
Several studies have demonstrated the safety of this procedure, which has a low percentage
of renovascular complications and is not associated with significant changes in renal function
at follow-up [2–4,19]. In addition, RD not only does not impair renal function but has the
potential of improving the incidence of albuminuria [5]. Animal studies have failed to demon-
strate significant inflammatory signs in the renal arteries at follow-up [20].
However, some authors have reported the development of new onset renal artery stenosis
after RD [21–23]. In addition, acute studies with OCT [6,24] demonstrated the presence of
post-procedural vasospasm, wall edema and thrombus formation after RD. Overall, the clinical
impact of those findings is unknown.
Our study supports the safety data arising from the main RD trials by showing no chronic
negative effects of RD on renal arteries. Both renal artery sharpness and distensibility had not
significantly changed at 6 month follow-up. Regarding renal artery sharpness, it is a
Fig 6. Example of wall shear stress analysis. At 6 month follow-up significantly lower values of wall shear stress (blue) are noted. In addition, enlargement
of the renal arteries at follow-up compared to baseline can be observed.
doi:10.1371/journal.pone.0150662.g006
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measurement of image quality of the MR angiograms and, as a consequence, of its reliability to
detect significant changes in the renal arteries. The fact, that there was no change after 6
months indicates no major damage of the vessel wall, causing decreased delineation of the
renal artery wall. Although animal histological data have shown the presence of significant
fibrosis in the adventitia and media layers following RD [20,25], our data suggests that such
histological changes cause no impairment of renal artery function in humans.
Another finding of our study is the evidence of an increase in renal artery minimal and max-
imal cross-sectional areas by 25.3% and 24.6%, respectively. This is likely the consequence of
disruption of effective sympathetic nerve stimulation with RD and contrasts with the results of
a recent CT renal angiography study, in which the authors found no significant changes in
renal artery diameter or area at 1 year follow-up [26]. The discrepancy between our results and
those of Zhang and colleagues is probably due to the fact that CT angiography, unlike phase-
contrast MR, is not a dynamic test and, as a consequence, changes in renal artery area with
blood pulse (i.e., maximal and minimal cross sectional areas) cannot be accurately assessed,
making the results from two different scans difficult to compare.
We have also demonstrated that the reduction in sympathetic stimuli with RD leads to an
increase by 16.9% in peak velocity and by 22.4% in mean flow. This finding is concordant with
prior data from animal experiments. In a swine model study it was demonstrated that RD
causes an acute increase in renal artery peak velocity and renal blood flow, which persists at fol-
low-up [8]. In the same study, the authors argue that an increase in these parameters could be
useful as a marker of effective sympathetic disruption at renal artery level. If such markers were
to be used, MR could be employed to perform a non-invasive, radiation-free assessment of
renal artery hemodynamics as well as to rule out potential complications of RD at the renal
artery level.
Importantly, we found the aforementioned changes in both responders and non-responders
to RD. This is concordant with reports of RD showing effects on left ventricular mass and func-
tion that are independent of blood pressure reduction [10,27]. Our findings suggest that
achieving a reduction in sympathetic stimulation at the renal artery levelmay not be enough to
produce a sustained reduction in blood pressure in some patients. Recent human studies have
shown that renal nerve density is lower in distal segments of the renal arteries [28]. Lack of
effective denervation has been suggested as a cause for non-response [29–31].
Finally, we found a decrease in renal artery wall shear stress, as assessed with computerized
flow analysis. Although the decrease in renal artery wall shear stress in our study is consistent
with the observed increase in cross-sectional areas, its clinical significance is unclear and was
not investigated in the present study. Further works should shed more light on this subject.
Limitations
Our work is based on a single center study, with a relatively small population. This is particu-
larly true of the flow simulation data which is time-consuming and requires advanced compu-
tation. This should be taken into account when interpreting the results, and limits the
evaluation of subgroups, although the intraclass correlation coefficient revealed excellent intra-
and interobserver reproducibility of our measurements. Our study lacks a control group; there-
fore, it cannot be ruled out that the changes observed are due to antihypertensive treatment or
natural history of the disease. New studies including a higher number of patients and controls
are needed to confirm our results. We did not investigate the effects of renal artery anatomy,
branching, and number and localisation of the ablation points on our measurements. This
should also be further explored. Finally, our follow-up period was limited to 6 months; there-
fore, the results at later time points could potentially vary and cannot be predicted.
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Conclusions
Our results demonstrate for the first time that RD is not associated with long-term detrimental
effects on renal arteries in humans. After RD the sympathetic stimuli in the renal arteries are
effectively disrupted, causing vasodilation of the renal arteries, increasing their flow and flow
velocity, and reducing wall shear stress. Finally, the clinical relevance of the changes observed
in the renal arteries after RD should be investigated in further studies.
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